Bisphosphocin Nu-3
LAI2014-1
Phase 2 small_molecule completed
Quick answer
Bisphosphocin Nu-3 for Diabetic Foot Infections is a Phase 2 program (small_molecule) at Lakewood-Amedex Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lakewood-Amedex Biotherapeutics
- Indication
- Diabetic Foot Infections
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed